Quantcast

Latest Adenocarcinoma Stories

2008-08-30 09:00:20

By Gologan, Adrian Acquafondata, Marie; Dhir, Rajiv; Sepulveda, Antonia R Context.-Polymeric immunoglobulin receptor (PIgR) expression has been found in gastric mucosa and gastric cancers, but it is not known whether PIgR expression is related to background intestinal metaplasia nor the patterns of PIgR expression in tumors arising in the distal esophagus and gastroesophageal (GE) junction. Objectives.- To identify clinicopathologic features of tumors associated with PIgR expression and to...

2008-07-21 06:00:17

U.S. and Canadian researchers have taken steps toward developing a gene test to determine whether a patient's lung cancer is especially aggressive or whether radical treatment can be avoided. The researchers reported Sunday that they had analyzed lung cancer tissue from 442 people to confirm that measuring the activity of certain genes could help predict early on which cases may be the most deadly and which had a better prognosis. Knowing whether a person has an aggressive tumor - one...

2008-07-20 03:00:15

By El-Abd, E El-Tahan, R; Fahmy, L; Zaki, S; Faid, W; Sobhi, A; Kandil, K; El-Kwisky, F ABSTRACT This study investigates the possible prognostic role of serum metastasin messenger RNA (mRNA) in breast carcinoma as a non- invasive screening tool, and determines metastasin mRNA in the serum of breast cancer patients with high sensitivity (85%) and specificity (100%). A significant difference (P=0.05) was observed between serum metastasin mRNA and the number of involved lymph nodes. Patients...

2008-07-18 09:01:12

BioNumerik Pharmaceuticals has announced that patients with adenocarcinoma participating in a Phase II clinical trial of Tavocept showed a survival increase of approximately 198 days. The trial observations included an approximate 40% reduction in mortality for adenocarcinoma patients receiving Tavocept. The percentage of adenocarcinoma patients in the Tavocept group who were alive after 12 months (one-year survival) was 58% compared to 37% for adenocarcinoma patients in the chemotherapy...

2008-07-17 09:00:19

SAN ANTONIO, July 17 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") today announced that patients with adenocarcinoma (the most frequently occurring form of lung cancer) participating in a Phase II clinical trial of Tavocept(TM) showed a survival increase of approximately 198 days (6.5 months). The trial observations included an approximate 40% reduction in mortality for adenocarcinoma patients receiving Tavocept. The percentage of adenocarcinoma patients in the Tavocept...

2008-07-16 03:00:17

By Butnor, Kelly J * Context.-Given the magnitude of the therapeutic and prognostic implications, it is critical that pathologists diagnose lung cancer accurately. This can sometimes be a formidable challenge, as a number of benign entities mimic lung carcinoma and vice versa. Objective.-To present strategies for recognizing benign entities likely to be confused with lung carcinoma, malignancies of the lung prone to misinterpretation as benign, and commonly misclassified pulmonary...

2008-07-16 03:00:16

By Allen, Timothy Craig The diagnosis of pulmonary malignant neoplasia generally portends a poor prognosis. The facts are stark. Worldwide, lung cancer is expected to increase in prevalence during the 21st century.1 Lung cancer is the leading cause of cancer death in both men and women in the United States. One in 10 cigarette smokers will develop lung cancer during his or her lifetime, with a decades-static overall 5- year survival rate for lung cancer in the United States of approximately...

2008-07-16 03:00:16

By Franks, Teri J Galvin, Jeffrey R * Context.-Tumors with neuroendocrine morphology are a distinct subset of lung neoplasms sharing characteristic histologic, immunohistochemical, ultrastructural, and molecular features. Objective.-To review the current histologic classification and the diagnostic criteria for the major categories of neuroendocrine tumors of the lung. Data Sources.-Published classification systems from the World Health Organization and pertinent peer-reviewed articles...

2008-06-14 03:00:08

By Ricketts, Reva Tamboli, Pheroze; Czerniak, Bogdan; Guo, Charles C * Tumor-to-tumor metastasis is a rare phenomenon. Renal cell carcinoma is the most common recipient of tumor-totumor metastasis in malignant tumors. However, renal angiomyolipoma has not been reported to be a recipient. Here we report 2 cases of tumor-to- tumor metastasis to renal angiomyolipoma. In one case, the donor tumor originated from neuroendocrine carcinoma of the pancreas, and in the other case the donor tumor was...

2008-06-14 03:00:00

By diSibio, Guy French, Samuel W * Context.-Many studies have addressed metastatic patterns seen among various cancers. No recent studies, however, provide quantitative analyses of such patterns arising from a broad range of cancers based primarily on postmortem tissue analyses. Objective.- To provide a quantitative description of metastatic patterns among different primary cancers based on data obtained from a large, focused autopsy study. Design.-Review of data from 3827 autopsies,...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'